Vanguard Group Inc Timber Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.1 - $0.3 $295,213 - $885,639
2,952,133 Added 251.72%
4,124,900 $495,000
Q4 2021

Feb 14, 2022
BUY
$0.38 - $0.89 $15,984 - $37,436
42,064 Added 3.72%
1,172,767 $446,000
Q3 2021

Nov 12, 2021
BUY
$0.89 - $1.18 $118,703 - $157,382
133,375 Added 13.37%
1,130,703 $1.03 Million
Q2 2021

Aug 13, 2021
BUY
$1.06 - $2.25 $1.06 Million - $2.24 Million
997,328 New
997,328 $1.22 Million

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email